Skip to main content
OpenTrials

Clinical trial condition

Bacterial Infections

Explore clinical trials studying Bacterial Infections. Study availability and eligibility vary by location and protocol.

4,522 public trials 496 recruiting studies
Refine in advanced search Browse all conditions

Bacterial Infections trial results

Completed

COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine

NCT00466947

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Community-Acquired Infections, +14 more
Locations
  • GSK Investigational Site Godoy Cruz, Mendoza Province, Argentina
  • GSK Investigational Site Las Heras, Mendoza Province, Argentina
  • GSK Investigational Site Lujan de Cuyo, Mendoza Province, Argentina
  • GSK Investigational Site Villa Nueva, Mendoza Province, Argentina
View all 22 locations
View Trial Details
Completed

Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.

NCT00775138

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Bronchial Diseases, +7 more
Locations
  • Washington D.C., District of Columbia, United States
  • Philadelphia, Pennsylvania, United States
  • Sofia, Bulgaria
  • Athens, Greece
View all 18 locations
View Trial Details
Completed

Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

NCT02422264

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +20 more
Locations
  • GSK Investigational Site Carlton, Victoria, Australia
  • GSK Investigational Site Calgary, Alberta, Canada
  • GSK Investigational Site Halifax, Nova Scotia, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
View all 30 locations
View Trial Details
Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection

NCT01746108

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +5 more
Locations
  • GSK Investigational Site Krakow, Poland
  • GSK Investigational Site Warsaw, Poland
  • GSK Investigational Site Wroclaw, Poland
  • GSK Investigational Site Barnaul, Russia
View Trial Details
Completed

A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age

NCT03170609

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Clinical Research Atlanta Stockbridge, Georgia, United States
  • Kentucky Pediatric / Adult Research Bardstown, Kentucky, United States
  • J. Lewis Research, Inc. / Foothill Family Clinic Salt Lake City, Utah, United States
  • J. Lewis Research, Inc. / Foothill Family Clinic South Salt Lake City, Utah, United States
View Trial Details
Completed

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

NCT02412436

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations
  • Gaborone Prevention/Treatment Trials CRS (12701) Gaborone, Botswana
  • Kenya Medical Research Institute/Center for Disease Control (KEMRI/CDC) CRS (31460) Kisumu, Kenya
  • Durban Adult HIV CRS (11201) Durban, South Africa
  • Univ. of Witwatersrand CRS (11101) Johannesburg, South Africa
View Trial Details

Related conditions